register

News & Trends - Biotechnology

Race to develop coronavirus vaccine

Health Industry Hub | January 29, 2020 |

The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.

The Coalition for Epidemic Preparedness Innovations (CEPI) has requested the University use its recently developed rapid response technology to develop a new vaccine, which could be available worldwide in as little as six months.

UQ Vice-Chancellor and President Professor Peter Høj AC said the fluidity of the current outbreak represented a significant challenge to the international community.

“There is a lot that is still unknown regarding how easily the virus is able to be transmitted between humans,” he said.

“Working with CEPI, The University of Queensland is using its vaccine technology to respond to this global health challenge.”

Suppliers & Service Providers: Enhance business visibility, differentiate your brand and maximise your reach. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique digital media solutions.

Head of University’s School of Chemistry and Molecular Biosciences, Professor Paul Young said The University of Queensland had novel technology for the rapid generation of new vaccines from the knowledge of a virus’s genetic sequence information.

“The team hopes to develop a vaccine over the next six months, which may be used to help contain this outbreak,” he said.

“The vaccine would be distributed to first responders, helping to contain the virus from spreading around the world.”

Dr Keith Chappell, from UQ’s School of Chemistry and Molecular Biosciences and the Australian Institute for Bioengineering and Nanotechnology said the key to the speedy development of this potential vaccine was the ‘molecular clamp’ technology, invented by UQ scientists and patented by UniQuest.

“The University of Queensland’s molecular clamp technology provides stability to the viral protein that is the primary target for our immune defence,” he said.

“The technology has been designed as a platform approach to generate vaccines against a range of human and animal viruses and has shown promising results in the laboratory targeting viruses such as influenza, Ebola, Nipah and MERS coronavirus.”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


News & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer

AI-powered test to reshape use of hormone therapy in prostate cancer

Health Industry Hub | February 6, 2025 |

Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]

More


News & Trends - MedTech & Diagnostics

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Health Industry Hub | February 6, 2025 |

Vantive, formerly Baxter’s Kidney Care business, has officially launched as a standalone company. The move follows Baxter’s completion of the […]

More


News & Trends - MedTech & Diagnostics

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Health Industry Hub | February 6, 2025 |

An Australian medical technology company has introduced a test designed to identify obstructive sleep apnoea (OSA), broadening access to sleep […]

More


This content is copyright protected. Please subscribe to gain access.